FOLD vs NWSA · rev $528.3M vs rev $9.03B
Amicus Therapeutics Inc (FOLD) versus NWSA (NWSA) — a side-by-side from cached financials, not a winner call.
Amicus Therapeutics Inc (FOLD) is a biotechnology company listed on US.
NWSA (NWSA) common stock.
Latest reported FOLD revenue for 2024-12-31 was $528.3M. Net income was -$56.1M. Revenue was up 32.3% from 2023-12-31 to 2024-12-31. FOLD currently screens at market cap $1.80B.
Latest reported NWSA revenue for 2026-06-30 was $9.03B. Net income was $573.0M. Revenue was up 328.1% from 2025-06-30 to 2026-06-30. NWSA currently screens at market cap $0.
FOLD currently screens at market cap $1.80B. NWSA currently screens at market cap $0.
Not investment advice. Open the FOLD and NWSA stock pages for the full models.
Not investment advice.